← Back
Data updated: Mar 10, 2026
LNK INTL INC
Immunology
LNK INTL INC is a generic drug manufacturer focused on Immunology.
2017
Since
2
Drugs
-
Trials
33
Approved (2yr)
Recent Activity
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-15
Labeling
ACETAMINOPHEN AND IBUPROFEN 2026-01-02
ACETAMINOPHEN AND IBUPROFEN 2025-12-17
Labeling
ACETAMINOPHEN AND IBUPROFEN 2025-12-11
ACETAMINOPHEN AND IBUPROFEN 2025-10-22
Labeling
ACETAMINOPHEN AND IBUPROFEN 2025-10-22
Labeling
ACETAMINOPHEN AND IBUPROFEN 2025-10-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (0)
Company Info
- First Approval
- 2017-01-23
- Latest
- 2025-12-11
- Applications
- 2